industria farmaceutica en australia

Consulate General of the

Argentine Republic in Sydney

Perfil de Mercado

INDUSTRIA FARMACEUTICA en

Australia

Sección Comercial Consulado General de la Republica Argentina en Sydney – Australia

Diciembre 2010

INDICE

INTRODUCCION 1- Finalidad del estudio 2- Posición arancelaria y descripción del producto PRIMERA PARTE – EL MERCADO DE LA INDUSTRIA FARMACEUTICA EN AUSTRALIA 3- Situación actual 3.1 Sector externo y tarifas 3.2 Política regional australiana y acuerdos de libre comercio SEGUNDA PARTE – COSTOS Y DOCUMENTACION GENERAL 4- Costo de nacionalización 4.1 Aranceles de importación Apéndice I – Tratamiento arancelario australiano 4.2 Impuestos locales y aranceles 4.3 Despacho aduanero y documentos exigidos por Aduana 4.4 Costo de apertura de carta de crédito 5- Requisitos sanitarios 6- Standards y otros requisitos técnicos TERCERA PARTE – EVOLUCION DE LAS IMPORTACIONES 7-Cifras de importación 2009 Apéndice II – Evolución de las importaciones australianas de productos Farmacéuticos 2009 8. Participación de Argentina Apéndice III – Evolución y participación de la Argentina 9-Niveles de precios 10-Canales de comercialización 11-Principales centros de consumo 12-Embalaje y formas de etiquetado 12.1 Transporte CUARTA PARTE – ACCESO AL MERCADO AUSTRALIANO 13-Ingresar al mercado australiano 14-Zonas Francas 15-Ferias y exposiciones generales y especializadas 16-Asociaciones sectoriales 17-Publicaciones y sitios de interés 18-Listado de importadores

INTRODUCCION

1. FINALIDAD DEL ESTUDIO

El presente perfil de mercado, ha sido realizado por la Sección Comercial del Consulado General de la Republica Argentina en Sydney, Australia, conforme la metodología del “Manual de Promoción Comercial”, Subsecretaria de Relaciones Comerciales Internacionales, 2010. Trata de productos farmacéuticos y terapéuticos, bioquímica, genética, biología molecular, inmunológica, biología celular; dispositivos biomédicos tales como: aparatos de asistencia ventricular, aparatos de audición, prótesis de cadera y rodilla, mercado genético, toxinas y alimentos; plataformas tecnológicas tales como bioinformática, tecnologías de separación, biosensores y nano tecnología; Medicina Complementaria. Pretende facilitar información actualizada a fabricantes, exportadores argentinos y cámaras del sector, sobre el mercado de la Industria Farmacéutica Australiana. Este perfil de mercado informa acerca de algunos aspectos de la economía y de la política comercial externa australiana que puede afectar la comercialización de estos productos, quienes son y donde se encuentran los importadores de productos farmaceuticos en Australia. Asimismo, intentará señalar las modalidades de comercialización, sea que los agentes económicos interesados exporten en forma directa o indirecta y la relación logística central del comercio entre Argentina y Australia de productos farmaceuticos: volumen – flete.

2. POSICIONES ARANCELARIAS Y DESCRIPCION DE PRODUCTOS Nomenclatura comun MERCOSUR (N.C.M) 30.01 Glándulas y demás órganos para usos opoterápicos, desecados, incluso pulverizados; extractos de glándulas o de otros órganos o de sus secreciones, para usos opoterápicos; heparina y sus sales; las demás sustancias humanas o animales preparadas para uso terapéuticos o profilácticos, no expresadas ni comprendida en otra parte. 30.02 Sangre humana; sangre animal preparada para usos terapéuticos, profilácticos o de diagnostico; sueros especificados de animales o de personas inmunizados y demás componentes de la sangre; vacunas, toxinas, cultivos de microorganismos (con exclusión de las levaduras) y productos similares. 30.03 Medicamentos (con exclusión de los productos de las partidas 30.02, 30.05 o 30.06) constituidos por productos mezclados entre si preparados para usos terapéuticos o profilácticos, sin dosificar ni acondicionar para la venta al por menor. 30.04 Medicamentos (con exclusión de los productos de las partidas 30.02, 30.05 o 30.06) constituidos por productos mezclados o sin mezclar, preparados para usos terapéuticos o profilácticos, dosificados o acondicionados para la venta al por menor 30.05 Guatas, gasas, vendas y artículos análogos (por ejemplo: apositos, esparadrapos, sinapismos), impregnados o recubiertos de sustancias farmacéuticas o acondicionados para la venta al por menor con fines médicos, quirúrgicos, odontológicos o veterinarios. 30.06 Preparaciones y artículos farmacéuticos a que se refiere la nota 3 del capitulo.

PRIMERA PARTE – EL MERCADO DE LA INDUSTRIA FARMACEUTICA EN AUSTRALIA

3 – SITUACION ACTUAL La Industria Farmacéutica Australiana comprende un 1% del mercado farmacéutico mundial, con una facturación de U$S 14.200 millones. En su totalidad la Industria emplea unas 34.000 personas, a través de por lo menos 300 firmas e Instituciones, incluyendo manufacturación, investigación y ventas. Las exportaciones Australianas de la Industria farmacéutica han crecido de un poco mas de U$S 84 millones en 1985, a U$S 3.255 millones en 2007, convirtiéndose en una de las industrias líderes en volumen de exportación. La industria farmacéutica Australiana invierte en promedio U$S 625 millones en investigación y desarrollo. En total la industria farmacéutica mundial invierte unos U$S 45.000 millones en análisis y desarrollo, mostrando la tendencia al crecimiento de la industria mediante el descubrimiento de nuevos medicamentos. El costo promedio del desarrollo de un nuevo medicamento es de U$S 1.000 millones, y el tiempo que lleva en desarrollarla es de 12 a 15 años. Solo 5 de cada 10.000 compuestos investigados son testeados en pruebas clínicas. De esos 5 solo 1 es aprobado como apto para uso público. En promedio, solo 3 de cada 10 medicamentos desarrollados lograrán cubrir sus costos de elaboración totales (incluyendo análisis y desarrollo, pruebas clínicas, marketing, entre otros). Al ser los costos de análisis y desarrollo tan altos, las patentes y propiedades intelectuales se han convertido en un problema mayor para los integrantes de la Industria Farmacéutica. Las compañías farmacéuticas están continuamente trabajando en desarrollar drogas más efectivas para el tratamiento de distintas enfermedades. En el mundo hay más de 1.000 medicamentos nuevos a prueba para Mal de Alzheimer, Infarto, Fibrosis Quistica, Artritis y muchas otras enfermedades. Existen casi 400 medicamentos a prueba como tratamiento para el cáncer. En esta última década, más de 300 medicamentos fueron creados para tratar distintas enfermedades. Entre los cambios estructurales podemos resaltar falta de productividad en las lineas de produccion de medicamentos, vencimiento de patentes protegiendo drogas de gran potencial comercial y una declinación del retorno financiero de inversiones en analisis y desarrollo. 3.1 Sector externo y tarifas La industria de Salud y Medicina Australiana es conocida globalmente por su innovación, diversidad, tecnología, capacidad, análisis y desarrollo, y por su robusto sistema de Salud. La Industria Tecnológica Médica Australiana tuvo un ingreso anual de U$S 3.990 millones en 2006-2007. En el 2006 las exportaciones de la misma tenían un valor de aproximadamente U$S 1.092, y U$S 2.436 millones como valor de las importaciones para el mismo año. Dichas cifras nos muestran la sólida tendencia al comercio internacional de la Industria Médica y Farmacéutica, exportando aproximadamente el 87% de la producción local de la misma. La industria de maquinaria médica esta caracterizada por un pequeño número de compañías multinacionales (alrededor del 20% de la industria), y un gran número de pequeñas y medianas empresas (un 80% de la industria). Algunas de las empresas productoras de medicamentos Australianas son líderes mundiales. Entre ellas se encuentran ResMed y Cochlear. Según “IBIS World” la Industria de producción Médica y de Equipamiento Quirúrgico Australiana comprende aproximadamente 2.900 establecimientos y 10.320 empleados en 2007-2008. La Industria de Maquinaría Médica mundial tiene un valor estimado de U$S 146.160 millones, de este total Australia representa un 0,6%.

3.2 Política regional Australiana y acuerdos de libre comercio. Australia es uno de los iniciadores del APEC (Asia Pacific Economic Cooperation) cuyo punto más alto se alcanzo en 1994 cuando sus miembros acordaron un cronograma para la liberalización del comercio. Como consecuencia una de las prioridades de la política comercial externa reciente de Australia ha sido la negociación de Acuerdos Bilaterales de Comercio. En adición al acuerdo con Nueva Zelanda “Australian – New Zealand Closer Economic Relations Trade Agreemen” (ANZCERTA), Australia ha firmado otros acuerdos bilaterales de comercio (preferenciales): con Singapur (SAFTA); con Tailandia (TAFTA) y con los Estados Unidos, “Australia – United Status Free Trade Agreement” (AUSFTA), y esta negociando acuerdos preferenciales con China, Malasia, Chile, Países del Golfo, Japón y Corea. La firma del AUSFTA ha generado modificaciones en reglas de origen y propiedad intelectual (“Copyright Act 1968” y “Patents Act 1990”). Las preferencias otorgadas por Australia en el marco de los acuerdos firmados erosionan las otorgadas a los Países Menos Adelantados (LDC) y a los Países (o economías) en desarrollo dentro del Sistema Generalizado de Preferencias de UNCTAD (SGP).

SEGUNDA PARTE – COSTOS Y DOCUMENTACION GENERAL

4- COSTOS DE NACIONALIZACION 4.1. Aranceles de Importación Los aranceles aplicados por Australia a las posiciones de productos farmacéuticos pueden consultarse en el Apéndice I. La mayoría de las tarifas que afectan a las posiciones arancelarias descriptas en el punto 2, se ubican entre el 5% y el 7%. Australia aplica preferencias arancelarias y acceso libre a bienes originarios de 50 Países Menos Adelantados (LDC), Papua Nueva Guinea, Nueva Zelanda y Singapur, y preferencias tarifarías a 90 países (o economías) en desarrollo dentro del Sistema Generalizado de Preferencias de UNCTAD (SGP), algunas de las cuales benefician a la Argentina como PED. 4.2 Impuestos locales y aranceles. Además de los aranceles, las importaciones están sujetas al impuesto sobre bienes y servicios, “Goods and Services Tax o GST” (Equivalente al IVA). El GST se aplica desde el 1 de Julio del 2000, a la mayoría de los bienes locales e importados, y es el 10% sobre la base imponible de importación (valué of tasable import o VOT) en el caso de importados, formada por la suma de su valor de factura, más arancel exigible, mas el transporte o flete y el seguro. Un número limitado de bienes están exentos del GST: ciertos alimentos, salud, educación, guarderías, alquiler de viviendas y servicios financieros. Con respecto al valor en aduana debe considerarse que Australia es signataria del acuerdo de Valoración en Aduana GATT/OMC desde 1981. El órgano de aplicación es la oficina de impuestos equivalente a la AFIP en Argentina, o Australian Taxation Office, cuyo sitio Web para mayor información es www.ato.gov.au . Información adicional puede obtenerse asimismo a través de la aduana australiana, Australian Customs Service, www.customs.gov.au . 4.3. Despacho aduanero y documentos exigidos por la Aduana Australiana La declaración de aduanas es regida en Australia por el Customs Act de 1901. En octubre del 2005 se estableció el denominado “Integrated Cargo System” (ICS) para las importaciones que llegan a los terminales australianos. Los clientes o importadores “per se”, o a través de sus despachantes de aduana, deben registrarse en la Aduana Australiana (Australian Customs Services). El 99 % de los despachos se procesan electrónicamente.

Las declaraciones de importación dentro del sistema integrado de carga, (o sus embalajes) sujetas a restricciones de cuarentena, deben respetar los requerimientos tanto de la Aduana Australiana (ACS) como del Servicio de Inspección de Cuarentena Australiano (Australian Quarantine Inspection Service, AQUIS) Los principales documentos exigidos por el “Australian Custom Service” son: la factura comercial; el conocimiento de embarque; el certificado de cuarentena (si aplica); la lista de empaque (packing list). Puede eventualmente exigirse el documento de seguro (opcional) si el embarque es CIF. Los costos de depósito en muelle o aeropuerto en caso de demoras por problemas documentarios son altos en Australia, así como el transporte, la manipulación de la mercadería, depósito fiscales transcurrido el corto período gratuito de estiba en terminales, por lo cual conviene utilizar los servicios de un despachante de aduana local calificado (custom clearance agent) quien debe ser consultado con antelación para despachar la mercadería en forma inmediata y evitar así mayores costos. Los honorarios profesionales de un Despachante de Aduana en Australia, para el manejo de documentación y la gestión del ingreso de la mercadería en su territorio aduanero, parten de un valor medio de 200 AUD pudiendo llegar a 1000 AUD o más dependiendo de las dificultades. Deben preverse otras cargas o servicios en puerto (handling charges) los que podrían llegar a un estimativo entre un 3 o 4 % de su valor CIF (Fuente: Hellman Worldwide Logistics – NSW – Australia). Para mayor información http://www.customs.gov.au/site/page.cfm?u=4226 4.4. Costo de apertura de carta de crédito Existen muchas posibilidades. En caso de utilizarse una carta de crédito irrevocable (L/C), a la vista y a 30, 60, 90 días, proveedores que puedan ofrecer alternativas de pago superiores, 120 /180 días, seguramente tendrán mayores posibilidades. Según fuente consultada el costo sería de aproximadamente 170 AUD mas el 0.3 % sobre el valor CIF (sin precisar si otros costos podrían estar presentes. La carta de crédito es una modalidad que protege principalmente al exportador cuando no hay experiencia comercial suficiente. Cuando hay un conocimiento mayor pueden utilizarse las transferencias bancarias. 5. REQUISITOS SANITARIOS Leyes, regulaciones y sistemas que rigen el producto importado. Australia aplica estrictas medidas sanitarias y fitosanitarias al ingreso de productos, incluyendo el “import risk análisis” que puede afectar al producto y embalaje. En particular aplica un sistema de cuarentena estricto destinado a proteger su sector Farmacéutico. Cabe tomar en cuenta que todo producto de madera o vegetal que pueda utilizarse para el embalaje de los productos farmacéuticos puede esta sujeto a inspecciones de cuarentena, por lo cual si el servicio de cuarentena lo considera necesario, dispone su fumigación previa al embarque en contenedor o destrucción en aduana, servicio que debe pagar el importador. Es aconsejable que los detalles sean consultados previamente por los respectivos despachantes de aduana intervinientes en el embarque, y que el contenedor sea sometido a fumigación bajo respectivo certificado. 6. STANDARDS Y OTROS REQUISITOS TECNICOS El marco institucional de las normas y estándares en Australia comprende cuatro cuerpos: “Standards Australia” organización que formula los estándares; la “Nacional Association of Testing Authorities” (NATA); el “Joint Accreditation System of Australia and New Zealand” (JAS-ANZ) y el “Nacional Measurement Institute” (NMI) establecido en julio de 2004 para integrar la metrología en física, química y biología.

Australia tiene dos tipos de estándares: voluntarios y regulatorios. La mayoría de los voluntarios son desarrollados y publicados por “Standards Australia”. Otros órganos privados operan en sectores específicos. En el caso de los productos Farmacéuticos deben seguirse ciertos estándares que pueden afectar la seguridad de los operadores. Conviene asimismo tener en cuenta el “Terapéutica Goods Administración (TGA), Guidance on the GMP clearance of oversease medicine manufacturers” (2008) sobre requerimientos de medicamentos www.tga.gov.au/manuf/gmpsom.htm .

TERCERA PARTE – EVOLUCION DE LAS IMPORTACIONES 7. Cifras de Importaciones de productos Farmacéuticos Con respecto a la importación Australiana de productos Farmacéuticos en el año 2009 cabe referirse al Apéndice II, Evolución de las Importaciones Australianas de productos Farmacéuticos 2009 que se incluye como anexo. 7.1. Participación de los países proveedores en las importaciones Los principales proveedores de productos farmacéuticos son Irlanda, Reino Unido, Estados Unidos, Suiza, España y Francia. Mayores precisiones pueden recabarse en el Apéndice II, relativas a cifras según proveedores. 8. Participación de Argentina Las importaciones de origen Argentino totalizaron 1.942.255 USD en el año 2009 conforme detalle Apéndice III. 9. Niveles de Precios de Productos Farmacéuticos

Producto Costo en AUD Fuente

Antiseptic Hand Sanitizer (100/bx)

$15,95 CFA Medical

BACROBIAL Ag™ Foaming Body Cleanser 8oz

$23,95 CFA Medical

Mygrex (MIGRAINE

HEADACHES) 150 X 2

$32.95 CFA Medical

Mouth Kote 8 oz $15,00 Parnell

Pharmaceuticals Anti-Fungal Cream

(Compare to Tinactine®)

144/Box

$16,95 CFA Medical

Ivarest® Cream (Poison Oak & Ivy)

100/Pack $27,95 CFA Medical

Pretz Concentrate $19,95 Parnell

Pharmaceuticals First Aid Burn

Cream (144/box) $14,95 CFA Medical

Actoset Forte 500/Box

$24,95 CFA Medical

Cough Drops Cherry (Compare to

Halls®) 50/Box $3,30 CFA Medical

Vitamin A & D Ointment Unit Dose

144/box $13,95 CFA Medical

Antacid (Compare

to Tums®) 500/Box

$15,95 CFA Medical

10 – CANALES DE COMERCIALIZACION Los productos Farmacéuticos son comercializados en Australia por importadores, mayoristas e importadores/productores. Ver punto 18, listado de importadores. Las ferias de productos Farmacéuticos y afines en Australia son buenos indicadores de la tendencia del mercado. Ver punto 16. Ferias y Exposiciones generales y especializadas. 11. PRINCIPALES CENTROS DE CONSUMO. Este extenso país tiene la mayoría de su población concentrada en la costa este y sudeste. Sus principales centros de consumo son: Sydney (7.191.500 habitantes); Melbourne (5.496.400 habitantes); Brisbane (4.473.000 habitantes); Perth (2.270.300 habitantes); Adelaida (1.633.900 habitantes) y Canberra (354.900 habitantes). Los principales puertos y terminales de Australia son: Brisbane, Dampier, Fremantle, Gladstone, Hay Pint, Melbourne, Newcastle, Port Hedland, Port Kembla, Port Walcott y Sydney. Las mayores terminales de carga aérea en Australia son el aeropuerto de Sydney, Melbourne y Brisbane. 12. EMBALAJES Y FORMAS DE ETIQUETADO Conviene prestar atención al material de embalaje utilizado, previo a la exportación, por el riguroso tratamiento fitosanitario de Australia a los productos que ingresan a su territorio aduanero. Por ejemplo en el caso de la madera, podría requerir la autorización del “Australian Quarantine and Inspection Service” (AQIS). Conviene asimismo, consultar previamente lo relativo a las normas de ingreso a través del propio importador, el despachante de aduana o el Consulado General de la Republica Argentina en Sydney, puesto que los costos de despacho y las demoras son altos en mercado. Las regulaciones australianas exigen en el caso de la importación de productos farmacéuticos y afines, la inscripción en idioma inglés, el país de origen, el tipo de producto del que se trata con su marca y logo, y una descripción de su contenido, peso y cantidad. Sin estas especificaciones podrían surgir problemas con el despacho a plaza por el “Australian Customs Service”. Para mayor información usted podrá consultar en mayor detalle requerimientos de etiquetado y embalaje enviando su consulta a [email protected] . 12.1 Transporte La ecuación volumen – precio es estratégica en el comercio de productos farmacéuticos entre Argentina y Australia, los embarques pueden realizarse desde Argentina por via marítima (45 días) via Singapur por ejemplo – como uno de los puertos posibles. La via aérea es un medio de mayor rapidez y costo. Pueden utilizarse las dos líneas aéreas directas a Australia via Santiago de Chile – Auckland –Sydney a la fecha de realización de este informe, o una alternativa es el courier aéreo misma via o por Estados Unidos.

CUARTA PARTE – ACCESO AL MERCADO AUSTRALIANO

13. Ingresar al Mercado Australiano El contacto directo con el importador por correo electrónico u otro medio, debe realizarse por medio de un texto rigurosamente preparado en inglés, y material ilustrativo de calidad también en inglés. De hecho serán las ilustraciones, o un folleto electrónico realizado por un profesional y no la cámara personal sobre una mesa de la fábrica la que podrá abrir la posibilidad comercial en Australia.

El contacto deberá completarse con el envío de un catálogo en inglés, su impresión profesional conviene que sea igual o mejor al producido localmente por las empresas comercializadoras del sector. Es imprescindible un sitio Web bilingüe, de buen diseño, con información acerca de la compañía, dirección, teléfonos, email y fax. En Australia es esencial el contacto personalizado y un seguimiento adecuado. 14. Zonas Francas La única zona franca existente en Australia fue creada en Septiembre de 1985 y es conocida como “Trade Development Zone” (TDZ). Esta situada en Darwin, capital del Territorio Norte, la zona menos desarrollada del país, y la más cercana al Sudeste Asiático. Es una zona especial de procesamiento industrial operada por la “Trade Development Authority”, orientada a la exportación. Las Industrias establecidas en dicha zona incluyen textiles, cartón y embalaje, representaciones gráficas en color, desarrollo de software, cerveza, emulsión de pescado, plantas de alimentos, inyección de plásticos y otros productos industriales. Cabe decir asimismo que el puerto de Brisbane, en Queensland, ha eliminado ciertas cargas por lo que su puerto opera, tomando como referencia el embarque marítimo, un veinte por ciento (20%) mas barato que Sydney y, un treinta y seis por ciento (-36%) menos que el de Melbourne. 15. Ferias y Exposiciones Generales y Especializadas 1- The Natural Health Conference and Expo PO Box 55 Glebe NSW 2037 Phone: 1300 789 845 Fax: 02 9660 9786 Email: [email protected] 2- Natural Healthcare Expo, Sydney. Natural Therapy Pages Level 3 46 - 56 Kippax St Surry Hills NSW 2010 Australia 3- Health@Melbourne Expo Janice Powell, Manager, Alumni and Events Advancement and Communications Faculty of Medicine, Dentistry and Health Sciences Phone: +61 3 8344 8058 Fax: +61 3 9347 8939 Email: [email protected] 4- Smiggins Ski Conference SMA Queensland Branch Suite 2.04 Sports House 150 Caxton St MILTON, QLD 4064 Phone:(07) 3367 2700 or 1800 007 501 (Regional) Fax: (07) 3367 2800 Email: [email protected]

5- ACSMS 2010 Jueves 4 de Noviembre 2010, Sheraton Mirage Resort Davina Sanders, Conference Manager Ph: 02 6241 9344 email [email protected] 6- STC 2010 Sabado, 13 Nov 2010 Sports House 375 Albert Road SOUTH MELBOURNE VIC 3205 Phone: (03) 9674 8777 Fax: (03) 9674 8799 [email protected] www.vic.sma.org.au 7- VIC Nursing and Health Expo 18 April 2010. Street Address: 1 Napier Close DEAKIN WEST ACT 2600 Postal Address: PO Box 219 DEAKIN WEST ACT 2600

16. Asociaciones Sectoriales

A- Australian Pharmaceutical Industries (API)

11 Grand Avenue Camellia, NSW 2142 Australia Phone: (02) 8844 2000 Fax: (02) 8844 2896Mailing Address: Locked Bag 5061 Parramatta, NSW 2124 Australia

B- Medicines Australia Level 1 16 Napier Close Deakin ACT 2600 Phone 02 6122 8500 Fax 02 6122 8555 Email [email protected] C- GS1 Australia Sydney Lakes Business Park, Building 4B, 2-4 Lord Street, Botany NSW 2019 Locked Bag 7002, Botany NSW 1455 Switch: 02 9700 0933 Fax: 02 9700 0820 D- ARCS Australia Ltd Suite 802, 28 Clarke Street CROWS NEST NSW 2065 Ph: 02 8905 0829 Fax: 02 8905 0830 Email: [email protected] Web: www.arcs.com.au

E- TGA – Therapeutic Goods Administration. TGA, PO Box 100, Woden ACT 2606, Australia Email: [email protected] Web: www.tga.gov.au F- Australian Doctor Fund. PO Box 12, Arncliffe NSW 2205 Telephone: 02 9567 5595 Facsimile: 02 9567 4050 Web: www.adf.com.au G- Nanostructural Analysis Network Organisation (NANO) Website: www.nano.org.au Contact: Dr Miles Apperley Phone: +61 2 9351 2887 Fax: +61 2 9351 7682 Email: [email protected] Address: Madsen Building (F09) The University Of Sydney NSW Australia 2006 H - National Health and Medical Research Council Clinical Trials Centre Website: www.ctc.usyd.edu.au Contact: Prof John Simes Phone: +61 2 9562 5000 Fax: +61 2 9565 1863 Email: [email protected] Address: Level 5, Building F 88 Mallett St Camperdown NSW Australia 2050 I - National Hearing Aid Systems Pty Ltd Contact: Mr Teck Loi Phone: +61 2 9413 2588 Fax: +61 2 9411 2950 Address: 126 Greville Street Chatswood NSW Australia 2067 J - National Institute of Complementary Medicine Professor Alan Bensoussan Executive Director Phone: +61 2 4620 3709 Email: [email protected] Website: www.nicm.edu.au K - National Measurement Institute Phone: +61 2 9449 0141 Fax: +61 2 9449 1653 Email: [email protected] Website: www.measurement.gov.au L- NeuClone Pty Ltd Phone: +612 9345 6992 Fax: +612 9661 3992 Email: [email protected] Website: www.neuclone.com

M - NeuMedix Health Group Phone: +61 2 9957 4796 Fax: +61 2 9957 4713 Email: [email protected] Address: Level 6 1 Elizabeth Plaza North Sydney NSW Australia 2060 N - Newcastle Bone and Joint Centre Website: www.newcastle.edu.au/faculty/health/resear Contact: Dr Nikolai Bogduk Phone: +61 2 4922 3505 Fax: +61 2 4922 3559 Email: [email protected] Address: Department of Clinical Research Newcastle Bone & Joint Centre Newcastle NSW Australia 2300 O – Australian Medical Association (AMA) Phone: 02 6270 5400 Fax: 02 6270 5499 Email: [email protected] Website: www.ama.com.au Postal Address: PO Box 6090 KINGSTON ACT 2604 Street Address: 42 Macquarie Street BARTON ACT 2600 17. Publicaciones y Sitios de Interes A- Australian Doctor http://www.australiandoctor.com.au B- Medical Observer www.medicalobserver.com.au C – Medical Hub www.medicalhub.com.au D – Nursing Post Magazine www.nursingpost.com.au E – Australian Journal of Medical Science B2B Magazines - Medicine & Healthcare Phone: 07 3876 2988 Web: www.aims.org.au 18. Listado de Importadores

Sanofi Aventis Group

Ref.No: 015764

ACN: 057 960 255

Email, Importer, Website

Subtitle: Division of Sterling Pharmaceuticals Pty Ltd - NSW Activity Group: Manufacturing;

Ascot Pharmaceuticals Proprietary Limited

Ref.No: 053022

ACN: 000 291 967

ABN: 44 000 291 967

Physical Address: Postal Address: 16 Byfield St

North Ryde NSW 2113 Australia

Locked Bag 2227 North Ryde BC NSW 1670

Australia

Phone: 61 2 8899 0700 Fax: 61 2 8899 0600

Freecall: 1800 818806

Email: [email protected]

Website: http://www.sanofi-synthelabo.com.au

Product Summary: Pharmaceuticals Year Established: 1994

Number of employees: 120

Annual turnover: $45,000,000

Bank: BNP Paribas Equities Australia Ltd Westpac Banking Corporation

Member Of: APMA;

Key Personnel: Medical Director: Victoria Elegant

General Manager: George Petrenas State Manager: Tom Leonard

Activity Group: Imp/Exp/Dist/Wholesale;

Physical Address: Postal Address: 213-233 Elizabeth St

CROYDON NSW 2132 Australia

P O Box 79 Croydon NSW 2132

Australia

Phone: 61 2 9798 9066 Fax: 61 2 9799 8948



Export Areas / Countries: Fiji, Papua New Guinea

Astra Tech

Ref.No: 105713

ABN: 46 112 267 133

Email, Exporter, Importer, Website

Australian Pharmaceutical Industries Limited

Ref.No: 014699

ACN: 000 004 320

ABN: 57 000 004 320

Website

Subtitle: Astra Tech Pty Ltd

Activity Group: Manufacturing; Imp/Exp/Dist/Wholesale;

Physical Address: Postal Address: Unit 1, 53 Grandview St

PYMBLE NSW 2073 Australia

Phone: 61 2 9488 3500 Fax: 61 2 9440 0744


Website: http://www.astratech.com

Product Summary: Medical/surgical devices Year Established: 0

Number of employees: Unknown

Products: 38891 Medical and surgical instruments (cont'd)

- 3889135-DEI - Instruments and catheters for urology and urodynamics 38910 Medical and surgical equipment

- 3891034-DEI - Spectroscopic equipment, medical diagnosis 63980 Pharmaceuticals (trade)

- 6398001-D - Medicines (trade) - 6398002-D - Parapharmaceutical preparations (trade)

67700 Hospital, medical, dentistry and veterinary equipment (trade) - 6770005-DEI - Medical and surgical instruments (trade)


Physical Address: Postal Address: 11 Grand Ave

ROSEHILL NSW 2142 Australia

Locked Bag 5061 Parramata NSW 2124

Australia

Clear Sales Australia Proprietary Limited

Ref.No: 079549

ABN: 75 061 414 275

Email, Website

Phone: 61 2 8844 2000 Fax: 61 2 8844 2401

Website: http://www.api.com.au

Product Summary: Pharmacy and medical wholesalers Year Established: 1910


Key Personnel: Chairman: Frank Conroy

Deputy Chairman: Barry Frost Sales Manager: David Young

:

Products: 63960 Cosmetics and toiletries (trade)

- 6396004-D - Cosmetics and creams (trade) 63980 Pharmaceuticals (trade)

- 6398001-D - Medicines (trade) 66500 Chemical products (trade)

- 6650012-D - Fine chemicals (trade)


Physical Address: Postal Address: Unit 1, 22 Hudson Ave,

CASTLE HILL NSW 2154 Australia

Phone: 61 2 9894 8888 Fax: 61 2 9894 8800


Website: http://www.clearsales.com.au



Products: 63980 Pharmaceuticals (trade)

- 6398001-D - Medicines (trade) - 6398002-D - Parapharmaceutical preparations (trade) - 6398003-D - Pharmaceutical oils and Vaseline (trade) - 6398017-D - Vitamins, hormones and organ extracts (trade) - 6398018-D - Antiseptics (trade)

Clifford Hallam Healthcare Proprietary Limited

Ref.No: 104924

ABN: 38 001 655 554

Qual. Rated, Website

Clifford Hallam Healthcare Pty Ltd

Ref.No: 058525

ABN: 38 001 655 554

Email, Qual. Rated, Website


Physical Address: Postal Address: 60 South Park Dr

DANDENONG SOUTH VIC 3175 Australia

Phone: 61 3 9554 0500 Fax: 61 3 9554 0400

Website: http://www.ch2.net.au

Product Summary: Pharmaceuticals and medical consumables Year Established: 0





Physical Address: Postal Address: 30-34 Eva St

ROSELANDS NSW 2196 Australia

P O Box 565 Riverwood NSW 2210

Australia

Douglas Pharmaceuticals Australia Limited

Ref.No: 058624

ABN: 17 003 854 626

Email, Website

Exportim (SA) Proprietary Limited

Ref.No: 036735

ACN: 007 784 463

Phone: 61 2 9584 4344 Fax: 61 2 9584 4374

Freecall: 1300 720 274


Website: http://www.ch2.net.au

Product Summary: Pharmaceuticals and medical consumables and equipment, Healthcare products and services

Year Established: 1973 Number of employees: 300




Physical Address: Postal Address: Unit 3, 10 Inglewood Place Baulkham Hills NSW 2153

Australia

P O Box 7004 Baulkham Hills BC NSW 2153

Australia

Phone: 61 2 8818 2111 Fax: 61 2 8818 2122


Website: http://www.douglas.com.au




- 6398001-D - Medicines (trade) - 6398002-D - Parapharmaceutical preparations (trade)

ABN: 44 007 784 063

Email, Exporter

HPS Pharmacies

Ref.No: 103879

ABN: 38 174 017 938

Email, Website


Physical Address: Postal Address: 3a Crystal Ave

St Marys SA 5042 Australia

Phone: 61 8 8277 3582 Fax: 61 8 8277 7957

Product Summary: Royal jelly products Year Established: 0


Export Areas / Countries: Europe, South Korea, Middle East, New Zealand

Key Personnel: Director: Effie Elovaris


- 6396004-DE - Cosmetics and creams (trade) - 6396010-DE - Soap, toilet (trade) - 6396012-DE - Haircare products (trade)

63980 Pharmaceuticals (trade) - 6398010-DE - Herbal medicines (trade)

Subtitle: HPS SA Activity Group: Imp/Exp/Dist/Wholesale;

Physical Address: Postal Address: 29 Alexander Ave Ashford SA 5035

Australia

Key Personnel: Partner: Janene Garde Partner: Stephen Furlan Partner: Trevor Draysey Partner: Amanda Francis

Polcopharma F Polley & Co Pty Ltd

Ref.No: 018292

Website


- 6398001-D - Medicines (trade) - 6398002-D - Parapharmaceutical preparations (trade) - 6398003-D - Pharmaceutical oils and Vaseline (trade


Physical Address: Postal Address: 35 Oxford St

EPPING NSW 2121 Australia

P O Box 100 Epping NSW 2121

Australia

Phone: 61 2 9876 6485 Fax: 61 2 9868 2266

Website: http://www.polcopharma.com.au

Product Summary: Herbal products Number of employees: 10

Key Personnel: Managing Director: Reinhard Polley


- 6396004-D - Cosmetics and creams (trade) 63980 Pharmaceuticals (trade)

- 6398010-D - Herbal medicines (trade)

Apéndice I - CUSTOMS TARIFF SCHEDULE 3

Section 6 R.6 Chapter 30/3

Reference Number

Statistical Code/Unit Goods Rate #

3001 GLANDS AND OTHER ORGANS FOR ORGANO-

THERAPEUTIC USES, DRIED, WHETHER OR NOT POWDERED; EXTRACTS OF GLANDS OR OTHER ORGANS OR OF THEIR SECRETIONS FOR ORGANO-THERAPEUTIC USES; HEPARIN AND ITS SALTS; OTHER HUMAN OR ANIMAL SUBSTANCES PREPARED FOR THERAPEUTIC OR PROPHYLACTIC USES, NOT ELSEWHERE SPECIFIED OR INCLUDED:

3001.20.00 07 .. - Extracts of glands or other organs or of their

secretions

Free

� � 3001.90.00 - Other Free

05 .. Glands and other organs, dried, whether or not powdered 08 .. Other

3002 HUMAN BLOOD; ANIMAL BLOOD PREPARED

FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA AND OTHER BLOOD FRACTIONS AND MODIFIED IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICRO-ORGANISMS (EXCLUDING YEASTS) AND SIMILAR PRODUCTS:

3002.10.00 23 .. - Antisera and other blood fractions and modified

immunological products, whether or not obtained by means of biotechnological processes

Free

3002.20.00 25 No† - Vaccines for human medicine Free 3002.30.00 27 .. - Vaccines for veterinary medicine Free 3002.90.00 - Other Free 10 kg Saxitoxin (CAS 35523-89-8) and salts thereof 11 kg Ricin (CAS 9009-86-3) and derivatives thereof 19 .. Other

3003 MEDICAMENTS (EXCLUDING GOODS OF 3002,

3005 OR 3006) CONSISTING OF TWO OR MORE CONSTITUENTS WHICH HAVE BEEN MIXED TOGETHER FOR THERAPEUTIC OR PROPHYLACTIC USES, NOT PUT UP IN MEASURED DOSES OR IN FORMS OR PACKINGS FOR RETAIL SALE:

3003.10.00 40 .. - Containing penicillins or derivatives thereof, with a

penicillanic acid structure, or streptomycins or their derivatives

Free

3003.20.00 42 .. - Containing other antibiotics Free

† No. of doses

# Unless otherwise indicated general rate applies for CA. Unless indicated in Schedule 5, rates for US originating goods are Free.

Section 6

CUSTOMS TARIFF SCHEDULE 3

Chapter 30/4 Reference Number


3003.3 - Containing hormones or other products of 2937 but

not containing antibiotics:

3003.31.00 44 IU - - Containing insulin Free

3003.39.00 46 .. - - Other Free

3003.40.00 48 .. - Containing alkaloids or derivatives thereof but not containing hormones or other products of 2937 or antibiotics

Free

3003.90.00 49 .. - Other Free

3004 MEDICAMENTS (EXCLUDING GOODS OF 3002,

3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (INCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS FOR RETAIL SALE:

3004.10.00 50 .. - Containing penicillins or derivatives thereof, with a

penicillanic acid structure, or streptomycins or their derivatives

Free

3004.20.00 52 .. - Containing other antibiotics Free

3004.3 - Containing hormones or other products of 2937 but

not containing antibiotics:

3004.31.00 54 IU - - Containing insulin Free

� 3004.32.00 56 .. - - Containing adrenal corticosteroid hormones, their derivatives or structural analogues

Free

3004.39.00 58 .. - - Other Free

3004.40.00 59 .. - Containing alkaloids or derivatives thereof but not

containing hormones, other products of 2937 or antibiotics

3004.50.00 61 .. - Other medicaments containing vitamins or other

products of 2936

Free Free

3004.90.00 63 .. - Other Free

# Unless otherwise indicated NZ, PG, FI, DC, LDC and SG rates are Free. � Operative 1/1/07 Unless otherwise indicated general rate applies for CA. Unless indicated in Schedule 5, rates for US originating goods are Free. Unless indicated in Schedule 6, rates for TH originating goods are Free. DCS denotes the rate for countries and places listed in Part 4 of Schedule 1 to this Act. DCT denotes the rate for HK, KR, SG and TW. If no DCT rate shown, DCS rate applies. If no DCT or DCS rate shown, general rate applies.


Section 6

R.4 Chapter 30/5 Reference Number


3005 WADDING, GAUZE, BANDAGES AND SIMILAR

ARTICLES (FOR EXAMPLE, DRESSINGS, ADHESIVE PLASTERS, POULTICES), IMPREGNATED OR COATED WITH PHARMACEUTICAL SUBSTANCES OR PUT UP IN FORMS OR PACKINGS FOR RETAIL SALE FOR MEDICAL, SURGICAL, DENTAL OR VETERINARY PURPOSES:

3005.10.00 01 .. - Adhesive dressings and other articles having an

adhesive layer

3005.90 - Other:

3005.90.10 02 .. - - - Wadding, including cotton wool and absorbent cotton

5% DCS:Free CA:Free 5%

3005.90.90 03 .. - - - Other 5%

DCS:Free CA:Free

# Unless otherwise indicated NZ, PG, FI, DC, LDC and SG rates are Free. 1/1/07 Unless otherwise indicated general rate applies for CA. Unless indicated in Schedule 5, rates for US originating goods are Free. Unless indicated in Schedule 6, rates for TH originating goods are Free. DCS denotes the rate for countries and places listed in Part 4 of Schedule 1 to this Act. DCT denotes the rate for HK, KR, SG and TW. If no DCT rate shown, DCS rate applies. If no DCT or DCS rate shown, general rate applies.

Section 6


Chapter 30/6 Reference Number


3006

PHARMACEUTICAL GOODS SPECIFIED IN NOTE 4 TO THIS CHAPTER:

� 3006.10 - Sterile surgical catgut, similar sterile suture materials (including sterile absorbable surgical or dental yarns) and sterile tissue adhesives for surgical wound closure; sterile laminaria and sterile laminaria tents; sterile absorbable surgical or dental haemostatics; sterile surgical or dental adhesion barriers, whether or not absorbable:

� 3006.10.1 - - - Sterile surgical or dental adhesion barriers, whether or not absorbable, of plastics:

� 3006.10.11 01 kg - - - - Of polymers of vinyl chloride, containing by weight not less than 6% of plasticisers, in the forms described in 3920

5% CA:Free

� 3006.10.12 02 kg - - - - Of plastics, in the forms described in 3920, as follows: (a) of polymers of ethylene; (b) of polymers of styrene; (c) of polymers of vinyl chloride, NSA; (d) of poly(vinyl butyral); (e) of polymides

5% CA:Free

� 3006.10.13 03 kg - - - - Of plastics, in the forms described in 3920, as follows: (a) of cellulose or its chemical derivaties; (b) of amino-resins; (c) of phenolic resins

Free

� 3006.10.14 04 kg - - - - Of plastics, in the forms described in 3921, as follows: (a) of polymers of styrene; (b) of vinyl chloride; (c) of polyurethanes

5% CA:Free

� 3006.10.15 05 kg - - - - Of cellulose or its chemical derivaties, coated, covered or laminated, NSA

Free

� 3006.10.19 06 kg - - - - Of other plastics 5% � 3006.10.2 - - - Sterile surgical or dental adhesion barriers,

whether or not absorbable, of textile fabrics:

� 3006.10.21 07 kg - - - - In the form of knitted or crocheted fabrics containing by weight 5% or more of elastomeric yarn or rubber thread

7.5% DC:2.5% CA:Free

From 1 January 2010 5% CA:Free

� 3006.10.22 08 kg - - - - Of other knitted or crocheted fabrics of a width not exceeding 30 cm

7.5% DC:2.5%

From 1 January 2010 5% � 3006.10.29 09 kg - - - - Of other knitted or crocheted fabrics 10%

DC:5% From 1 January 2010 5%

� 3006.10.90 10 .. - - - Other Free


3006.20.00

07 ..

- Blood-grouping reagents

Free

3006.30.00 09 .. - Opacifying preparations for X-ray examinations; diagnostic reagents designed to be administered to the patient

Free

3006.40.00 10 ..

- Dental cements and other dental fillings; bone reconstruction cements

5%

3006.50.00 25 No - First-aid boxes and kits Free 3006.60.00 26 .. - Chemical contraceptive preparations based on

hormones, on other products of 2937 or on spermicides

Free

3006.70.00

- Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments

5%

40 .. Human medicine 42 .. Veterinary medicine

� 3006.9 - Other:

� 3006.91.00 01 .. - - Appliances identifiable for ostomy use 5% CA:Free

� 3006.92 - - Waste pharmaceuticals: � 3006.92.10 02 .. - - - Goods, as follows:

(a) of goods of 3005.90.10; (b) of goods of 3006.40.00

5%

� 3006.92.20 03 .. - - - Of goods of 3005, NSA 5% DCS:Free CA:Free

� 3006.92.30 07 .. - - - Of goods of Chapter 30, NSA Free � 3006.92.90 05 .. - - - Other 5%

25


26

Apéndice II - Importaciones Australianas 2009

HTISC HTISC - Etiquetas Origen

AUS$ U$S

3001200007

Extracts of glands or other organs or of their

secretions Argentina

71,171.21 62,630.66

3001200007


secretions Canada

350,650.00 308,572.00

3001200007


secretions Denmark

1,709.40 1,504.27

3001200007


secretions Taiwan

1,606.75 1,413.94

3001200007


secretions

United Kingdom 1,177,864.24 1,036,520.53

3001200007


secretions

United States of America

345,834.81 304,334.63

3001900005

Glands and other organs, dried, whether or not

powdered Nepal

3,283.06 2,889.09

3001900005


powdered New Zealand

87,689.20 77,166.50

3001900005


powdered


11,704.06 10,299.57

3001900008

Herapin, its salts & human or animal substances

(excl. dried glands & other organs, extracts of glands or other organs or of their secretions, blood & blood

fractions & waste products) prepared for th

Australia (Re-imports)

2,000.00 1,760.00

3001900008




Austria

100,630.48 88,554.82

27

3001900008




China

25,934.55 22,822.40

3001900008




Denmark

3,903.07 3,434.70

3001900008




France

424,187.06 373,284.61

3001900008




Germany

58,406.12 51,397.39

3001900008




Ireland

2,854.47 2,511.93

3001900008




Israel

1,089.66 958.90

3001900008




Netherlands

1,142,042.37 1,004,997.29

28

3001900008




New Zealand

287,083.52 252,633.50

3001900008




United Kingdom

1,060,500.34 933,240.30

3001900008





2,550,609.66 2,244,536.50

3002100023

Antisera and other blood fractions and modified

immunological products, whether or not obtained

by means of biotechnological

processes

Albania

1,486.99 1,308.55

3002100023




processes


518,310.88 456,113.57

3002100023




processes

Austria

72,343,196.58 63,662,012.99

3002100023




processes

Belgium

12,549.69 11,043.73

29

3002100023




processes

Brazil

6,347.59 5,585.88

3002100023




processes

Canada

112,804.34 99,267.82

3002100023




processes

Chile

2,190.10 1,927.29

3002100023




processes

China

20,032.75 17,628.82

3002100023




processes

Czech Republic

10,004.23 8,803.72

3002100023




processes

Denmark

5,819,825.42 5,121,446.37

3002100023




processes

Finland

121,584.66 106,994.50

3002100023




processes

France

435,653.98 383,375.50

30

3002100023




processes

Germany

37,530,615.07 33,026,941.26

3002100023




processes

Hong Kong (SAR of China)

3,525,180.92 3,102,159.21

3002100023




processes

Indonesia

2,180.86 1,919.16

3002100023




processes

Ireland

11,157,007.74 9,818,166.81

3002100023




processes

Israel

106,241.98 93,492.94

3002100023




processes

Italy

2,763,440.89 2,431,827.98

3002100023




processes

Japan

1,231,419.37 1,083,649.05

3002100023




processes

Korea, Republic of

5,032.00 4,428.16

31

3002100023




processes

Malaysia

1,028,342.84 904,941.70

3002100023




processes

Netherlands

26,716,209.37 23,510,264.25

3002100023




processes

New Zealand

12,361,452.33 10,878,078.05

3002100023




processes

Norway

103,229.70 90,842.14

3002100023




processes

Puerto Rico

2,020,915.05 1,778,405.24

3002100023




processes

Singapore

903,009.23 794,648.12

3002100023




processes

Slovak Republic

6,292.89 5,537.74

3002100023




processes

South Africa

223,003.02 196,242.66

32

3002100023




processes

Spain

3,635,504.38 3,199,243.85

3002100023




processes

Sweden

35,645.34 31,367.90

3002100023




processes

Switzerland

145,798,439.77 128,302,627.00

3002100023




processes

Taiwan

3,735,268.05 3,287,035.88

3002100023




processes

United Kingdom

60,301,459.43 53,065,284.30

3002100023




processes


65,064,635.12 57,256,878.91

3002200025 Vaccines for human

medicine Australia (Re-

imports) 717,182.41 631,120.52


medicine Belgium 111,622,104.04 98,227,451.56


medicine Canada 5,589,136.24 4,918,439.89


medicine China 467,930.00 411,778.40


medicine Denmark 5,521,059.09 4,858,532.00


medicine France 25,104,091.30 22,091,600.34 3002200025 Vaccines for human Germany 1,918,729.57 1,688,482.02

33

medicine


medicine Italy 8,094.81 7,123.43


medicine Korea,

Republic of 1,894,542.04 1,667,197.00


medicine Netherlands 28,528,442.89 25,105,029.74


medicine New Zealand 182,651.91 160,733.68


medicine Singapore 993,738.65 874,490.01


medicine South Africa 10,108.81 8,895.75


medicine Sweden 2,483,757.67 2,185,706.75


medicine Switzerland 3,928,480.46 3,457,062.80


medicine United

Kingdom 821,402.77 722,834.44

3002200025

Vaccines for human medicine


158,895,446.06 139,827,992.53

3002300027 Vaccines for veterinary

medicine Australia (Re-

imports) 585,757.46 515,466.56


medicine Japan 1,245.33 1,095.89


medicine Netherlands 5,404,410.62 4,755,881.35


medicine New Zealand 1,990,019.60 1,751,217.25


medicine Spain 2,406,606.02 2,117,813.30


medicine United

Kingdom 248,100.34 218,328.30

3002300027

Vaccines for veterinary medicine


16,500,470.30 14,520,413.86

3002900019

Human blood; animal blood prepared for

therapeutic, prophylactic or diagnostic uses, toxins,

cultures of micro-organisms and similar products (excl. yeasts,

saxitoxin (CAS 35523-89-8) and salts thereo


71,046.66 62,521.06

3002900019




Austria

95,600.86 84,128.76

34


3002900019





Belgium

1,847.62 1,625.91

3002900019





Canada

970,659.37 854,180.25

3002900019





Chile

5,134.58 4,518.43

3002900019





China

64,248.09 56,538.32

3002900019





Denmark

7,628,727.62 6,713,280.31

35

3002900019





Finland

252,847.05 222,505.40

3002900019





France

2,474,099.82 2,177,207.84

3002900019





Germany

2,867,207.34 2,523,142.46

3002900019





India

35,624.39 31,349.46

3002900019





Ireland

34,071,011.99 29,982,490.55

3002900019





Israel

42,495.54 37,396.08

36

3002900019





Italy

480,677.50 422,996.20

3002900019





Japan

8,639.20 7,602.50

3002900019





Malaysia

112,934.34 99,382.22

3002900019





Netherlands

194,127.60 170,832.29

3002900019





New Zealand

278,567.13 245,139.07

3002900019





Papua New Guinea

1,168.06 1,027.89

37

3002900019





Spain

10,493.64 9,234.40

3002900019





Sweden

613,314.09 539,716.40

3002900019





Switzerland

10,612,454.33 9,338,959.81

3002900019





United Kingdom

7,075,823.08 6,226,724.31

3002900019






12,075,268.38 10,626,236.17

3003100040

Medicaments (excl. HS 3002, 3005 & 3006) with two or more constituents mixed, for therapeutic or

prophylactic use & containing penicillins or streptomycins or their

derivatives, not put up in measured

China

319,054.56 280,768.01

38

3003100040




Mexico

42,824.68 37,685.72

3003100040




Turkey

279,954.20 246,359.70

3003100040





945,014.05 831,612.36

3003200042

Medicaments with two or more constituents mixed,

for therapeutic or prophylactic use &

containing antibiotics (excl. HS 3002, 3005 &

3006, penicillins or streptomycins or their derivatives) not put up

Hungary

24,933.21 21,941.22

3003200042





India

562,977.05 495,419.80

3003200042





Macau (SAR of China)

2,637,584.18 2,321,074.08

39

3003200042





New Zealand

533,323.10 469,324.33

3003200042





Puerto Rico

426,004.20 374,883.70

3003200042





Spain

461,484.62 406,106.47

3003200042





United Kingdom

32,811.44 28,874.07

3003200042






329,859.39 290,276.26

3003390046

Medicaments consist of two or more constituents,

for therapeutic or prophylactic use & contain hormones or products of

2937 (excl. HS 3002, 3005 & 3006 & insulin) not contain antibiotics, not put

up i

China

9,018.19 7,936.01

40

3003390046




up i

Ireland

3,618,619.36 3,184,385.04

3003390046




up i

Norway

3,870,988.68 3,406,470.04

3003390046




up i


2,672.80 2,352.06

3003400048

Medicaments (excl. HS 3002, 3005 & 3006)

consist of two or more constituent, for therapeutic

or prophylactic use & contain alkaloids or derivs, not contain hormones, HS 2937 or antibiotics, not put

up

Czech Republic

19,747.03 17,377.39

3003400048

Medicaments (excl. HS 3002, 3005 & 3006)

consist of two or more constituent, for therapeutic

or prophylactic use & contain alkaloids or derivs, not contain hormones, HS 2937 or antibiotics, not put

up


59,508.59 52,367.56

3003900049

Medicaments with two or more constituents, for

therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing

penicillins, antibiotics, alkoloids, hormones or HS

2937 & derivs) not in m


64,287.46 56,572.96

41

3003900049





Austria

1,102,920.88 970,570.37

3003900049





Belgium

46,730.98 41,123.26

3003900049





Brazil

333,382.67 293,376.75

3003900049





Canada

9,528,299.36 8,384,903.44

3003900049





China

3,075,647.80 2,706,570.06

3003900049





Cyprus

284,400.67 250,272.59

3003900049





Czech Republic

65,143.75 57,326.50

42

3003900049





Denmark

53,477.67 47,060.35

3003900049





France

818,983.60 720,705.57

3003900049





Germany

1,447,406.24 1,273,717.49

3003900049





Hungary

161,823.31 142,404.51

3003900049





Iceland

232,281.04 204,407.32

3003900049





India

990,206.99 871,382.15

3003900049





Iran

168,750.00 148,500.00

43

3003900049





Ireland

23,892,960.89 21,025,805.58

3003900049





Israel

152,943.51 134,590.29

3003900049





Italy

768,690.37 676,447.53

3003900049





Japan

661,260.67 581,909.39

3003900049





Korea, Republic of

10,945.94 9,632.43

3003900049





Malta

112,361.11 98,877.78

3003900049





Netherlands

23,832.62 20,972.71

44

3003900049





New Zealand

1,754,620.81 1,544,066.31

3003900049





Norway

77,033.92 67,789.85

3003900049





Portugal

30,282.87 26,648.93

3003900049





Samoa

1,137.39 1,000.90

3003900049





Singapore

1,567,860.14 1,379,716.92

3003900049





Slovak Republic

291,313.69 256,356.05

3003900049





South Africa

1,194.00 1,050.72

45

3003900049





Spain

509,215.94 448,110.03

3003900049





Sweden

910,034.41 800,830.28

3003900049





Switzerland

29,794.95 26,219.56

3003900049





United Kingdom

1,518,534.52 1,336,310.38

3003900049






9,670,452.45 8,509,998.16

3004100050

Medicaments (excl. HS 3002, 3005 or 3006) consist of mixed or unmixed goods, for

therapeutic or prophylactic use, containing penicillins,

streptomycins or their derivs, in measured dose

(incl. transde


1,309.80 1,152.62

3004100050



streptomycins or their

Austria

4,741,099.00 4,172,167.12

46

derivs, in measured dose (incl. transde

3004100050




(incl. transde

Belgium

24,218.39 21,312.18

3004100050




(incl. transde

France

3,404,652.71 2,996,094.38

3004100050




(incl. transde

Germany

2,158,408.50 1,899,399.48

3004100050




(incl. transde

India

8,066,895.16 7,098,867.74

3004100050




(incl. transde

Ireland

1,091,140.88 960,203.97

47

3004100050




(incl. transde

Italy

2,341,940.33 2,060,907.49

3004100050




(incl. transde

Netherlands

585,408.97 515,159.89

3004100050




(incl. transde

New Zealand

250,442.18 220,389.12

3004100050




(incl. transde

Spain

842,753.08 741,622.71

3004100050




(incl. transde

Switzerland

166,434.31 146,462.19

3004100050




(incl. transde

United Kingdom

18,332,350.93 16,132,468.82

48

3004100050




(incl. transde


405,578.39 356,908.98

3004200052

Medicaments of mixed or unmixed goods, for

therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &

3006, penicillins or streptomycins or derivs) in measured dose (incl. for

transde


209,710.30 184,545.06

3004200052




transde

Austria

5,333,401.75 4,693,393.54

3004200052




transde

Belgium

5,817,567.63 5,119,459.51

3004200052




transde

Brazil

1,665,127.06 1,465,311.81

3004200052




transde

Canada

811,191.09 713,848.16

49

3004200052




transde

China

460,138.62 404,921.99

3004200052




transde

Colombia

508,588.67 447,558.03

3004200052




transde

Denmark

2,326,384.47 2,047,218.33

3004200052




transde

France

35,575,413.27 31,306,363.68

3004200052




transde

Germany

14,479,059.42 12,741,572.29

3004200052




transde

Hungary

12,394.36 10,907.04

50

3004200052




transde

India

9,408,746.35 8,279,696.79

3004200052




transde

Iran

206,368.36 181,604.16

3004200052




transde

Ireland

6,025,802.05 5,302,705.80

3004200052




transde

Italy

20,139,792.23 17,723,017.16

3004200052




transde

Japan

21,474,243.96 18,897,334.68

3004200052




transde

Netherlands

1,097,186.76 965,524.35

51

3004200052




transde

New Zealand

1,698,551.66 1,494,725.46

3004200052




transde

Norway

1,520,930.47 1,338,418.81

3004200052




transde

Philippines

239,499.32 210,759.40

3004200052




transde

Puerto Rico

159,624.97 140,469.97

3004200052




transde

Romania

66,466.13 58,490.19

3004200052




transde

Saudi Arabia

12,622.80 11,108.06

52

3004200052




transde

Sierra Leone

59,041.24 51,956.29

3004200052




transde

Singapore

2,956,561.60 2,601,774.21

3004200052




transde

Slovenia

1,445,392.90 1,271,945.75

3004200052




transde

South Africa

6,015.22 5,293.39

3004200052




transde

Spain

9,403,635.17 8,275,198.95

3004200052




transde

Sweden

6,194,228.38 5,450,920.97

53

3004200052




transde

Switzerland

3,880,619.86 3,414,945.48

3004200052




transde

Turkey

769,765.34 677,393.50

3004200052




transde

United Kingdom

8,199,090.28 7,215,199.45

3004200052




transde


141,932,682.36 124,900,760.48

3004310054

Medicaments (excl. HS 3002, 3005 or 3006) of

mixed or unmixed goods, for therapeutic or

prophylactic uses & containing insulin but not containing antibiotics, in

measured doses (incl. for transdermal

Canada

4,848.33 4,266.53

3004310054





Denmark

42,614,600.25 37,500,848.22

54

3004310054





France

37,626,209.44 33,111,064.31

3004310054





Germany

20,995,615.30 18,476,141.46

3004310054





Netherlands

1,041,383.62 916,417.59

3004310054





United Kingdom

75,707.95 66,623.00

3004310054






1,803,890.18 1,587,423.36

3004320056

Medicaments (excl. HS 3002, 3005 & 3006) mixed

or unmixed, for therapeutic or prophylactic

use & contain corticosteroid hormone or

deriv or structural analogues but not contain

antibiotic, in measured

Austria

82,742.98 72,813.82

55

3004320056






Belgium

18,736,496.62 16,488,117.03

3004320056






Finland

118,647.15 104,409.49

3004320056






France

3,353,554.58 2,951,128.03

3004320056






Germany

5,348,324.67 4,706,525.71

3004320056






India

1,995,676.77 1,756,195.56

3004320056






Ireland

261,100.83 229,768.73

56

3004320056






Israel

25,106.99 22,094.15

3004320056






Italy

325,318.16 286,279.98

3004320056






Netherlands

2,040.42 1,795.57

3004320056






Singapore

201,140.93 177,004.02

3004320056






Sweden

53,094,206.64 46,722,901.84

3004320056






Switzerland

1,334.78 1,174.61

57

3004320056






United Kingdom

97,192.02 85,528.98

3004320056







1,998,461.57 1,758,646.18

3004390058

Medicaments, mixed or unmixed, for therapeutic

or prophylactic use & contain hormones or

goods of 2937 (excl. HS 3002, 3005 & 3006,

insulin & corticosteroid hormone & derivs) not

contain antibiotics,


12,724.48 11,197.54

3004390058



goods of 2937 (excl. HS 3002, 3005 & 3006,



Austria

11,564,708.99 10,176,943.91

3004390058



goods of 2937 (excl. HS 3002, 3005 & 3006,



Belgium

5,459,165.71 4,804,065.82

3004390058



goods of 2937 (excl. HS 3002, 3005 & 3006,



Canada

183,904.02 161,835.54

58

3004390058



goods of 2937 (excl. HS 3002, 3005 & 3006,



China

2,781.90 2,448.07

3004390058



goods of 2937 (excl. HS 3002, 3005 & 3006,



Denmark

13,869,816.67 12,205,438.67

3004390058



goods of 2937 (excl. HS 3002, 3005 & 3006,



Fiji

939,185.06 826,482.85

3004390058



goods of 2937 (excl. HS 3002, 3005 & 3006,



Finland

126,832.77 111,612.84

3004390058



goods of 2937 (excl. HS 3002, 3005 & 3006,



France

17,345,200.25 15,263,776.22

3004390058



goods of 2937 (excl. HS 3002, 3005 & 3006,



Germany

22,209,255.00 19,544,144.40

59

3004390058



goods of 2937 (excl. HS 3002, 3005 & 3006,



India

163,194.06 143,610.77

3004390058



goods of 2937 (excl. HS 3002, 3005 & 3006,



Ireland

35,476,564.14 31,219,376.44

3004390058



goods of 2937 (excl. HS 3002, 3005 & 3006,



Italy

11,594,668.54 10,203,308.32

3004390058



goods of 2937 (excl. HS 3002, 3005 & 3006,



Japan

14,083,772.36 12,393,719.68

3004390058



goods of 2937 (excl. HS 3002, 3005 & 3006,



Netherlands

12,779,232.76 11,245,724.83

3004390058



goods of 2937 (excl. HS 3002, 3005 & 3006,



New Zealand

2,047,991.98 1,802,232.94

60

3004390058



goods of 2937 (excl. HS 3002, 3005 & 3006,



Puerto Rico

256,218.63 225,472.39

3004390058



goods of 2937 (excl. HS 3002, 3005 & 3006,



Singapore

19,201.24 16,897.09

3004390058



goods of 2937 (excl. HS 3002, 3005 & 3006,



Spain

2,000.00 1,760.00

3004390058



goods of 2937 (excl. HS 3002, 3005 & 3006,



Sweden

4,120,245.83 3,625,816.33

3004390058



goods of 2937 (excl. HS 3002, 3005 & 3006,



Switzerland

14,957,372.19 13,162,487.53

3004390058



goods of 2937 (excl. HS 3002, 3005 & 3006,



United Kingdom

39,297,022.42 34,581,379.73

61

3004390058



goods of 2937 (excl. HS 3002, 3005 & 3006,




152,838,367.94 134,497,763.79

3004400059

Medicaments (excl. HS 3002, 3005 or 3006)

mixed or unmixed, for therapeutic or prophylactic use and contain alkaloids or derivs but not contain hormones or products of

2937 or antibiotics, in measured

Argentina

977,582.97 860,273.01

3004400059





553,223.23 486,836.44

3004400059




Belgium

237,948.82 209,394.96

3004400059




Canada

121,907.19 107,278.33

3004400059




China

5,367.91 4,723.76

62

3004400059




France

3,350,249.15 2,948,219.25

3004400059




Germany

6,172,703.59 5,431,979.16

3004400059




Greece

20,702.12 18,217.87

3004400059




Hungary

320,544.11 282,078.82

3004400059




India

7,316,133.70 6,438,197.66

3004400059




Italy

1,882,600.49 1,656,688.43

63

3004400059




Japan

26,467.72 23,291.59

3004400059




Netherlands

347,471.34 305,774.78

3004400059




New Zealand

1,540,644.39 1,355,767.06

3004400059




Singapore

900,012.94 792,011.39

3004400059




Slovak Republic

612,476.94 538,979.71

3004400059




South Africa

743,000.67 653,840.59

64

3004400059




Spain

890,718.86 783,832.60

3004400059




Switzerland

44,990.39 39,591.54

3004400059




United Kingdom

20,962,792.27 18,447,257.20

3004400059





361,916.18 318,486.24

3004500061



prophylactic use, contain vitamins or products of

2936, in measured doses (incl. those of transdermal

administra


30,601.81 26,929.59

3004500061





administra

Canada

13,738,429.59 12,089,818.04

65

3004500061





administra

China

1,256,405.84 1,105,637.14

3004500061





administra

Denmark

2,799,402.55 2,463,474.24

3004500061





administra

Finland

167,627.12 147,511.87

3004500061





administra

France

147,805.97 130,069.25

3004500061





administra

Germany

6,461,858.55 5,686,435.52

3004500061





administra


6,847.90 6,026.15

66

3004500061





administra

India

2,805,254.15 2,468,623.65

3004500061





administra

Indonesia

12,447,406.27 10,953,717.52

3004500061





administra

Italy

152,999.02 134,639.14

3004500061





administra

Netherlands

1,285,979.89 1,131,662.30

3004500061





administra

New Zealand

18,077,303.14 15,908,026.76

3004500061





administra

Norway

65,935.05 58,022.84

67

3004500061





administra

Singapore

185,933.78 163,621.73

3004500061





administra

South Africa

1,295.09 1,139.68

3004500061





administra

Spain

270,830.16 238,330.54

3004500061





administra

Sweden

28,968.91 25,492.64

3004500061





administra

Switzerland

1,535,669.98 1,351,389.58

3004500061





administra

United Kingdom

9,464,624.47 8,328,869.53

68

3004500061





administra


4,522,299.45 3,979,623.52

3004900063

Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,

3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or

derivs & vitamins or HS 2936) in measured dose

(incl. for tr

Argentina

1,158,354.08 1,019,351.59

3004900063




(incl. for tr


5,400,325.36 4,752,286.32

3004900063




(incl. for tr

Austria

24,056,049.11 21,169,323.22

3004900063




(incl. for tr

Belgium

216,367,499.34 190,403,399.42

3004900063




(incl. for tr

Belize

4,507.53 3,966.63

69

3004900063




(incl. for tr

Brazil

930,869.22 819,164.91

3004900063




(incl. for tr

Canada

46,471,310.40 40,894,753.15

3004900063




(incl. for tr

China

15,295,684.41 13,460,202.28

3004900063




(incl. for tr

Cyprus

1,856,908.82 1,634,079.76

3004900063




(incl. for tr

Czech Republic

1,293,791.12 1,138,536.19

3004900063




(incl. for tr

Denmark

49,739,692.68 43,770,929.56

70

3004900063




(incl. for tr

Fiji

1,290,554.06 1,135,687.57

3004900063




(incl. for tr

Finland

36,637,315.21 32,240,837.38

3004900063




(incl. for tr

France

662,239,903.68 582,771,115.24

3004900063




(incl. for tr

French Guiana

1,376.06 1,210.93

3004900063




(incl. for tr

Germany

690,271,684.26 607,439,082.15

3004900063




(incl. for tr

Greece

26,138,658.11 23,002,019.14

71

3004900063




(incl. for tr

Guinea

81,065.80 71,337.90

3004900063




(incl. for tr


1,320,727.38 1,162,240.09

3004900063




(incl. for tr

Hungary

435,423.36 383,172.56

3004900063




(incl. for tr

Iceland

310,570.81 273,302.31

3004900063




(incl. for tr

India

58,418,753.20 51,408,502.82

3004900063




(incl. for tr

Indonesia

1,817,919.65 1,599,769.29

72

3004900063




(incl. for tr

Iran

614,657.57 540,898.66

3004900063




(incl. for tr

Ireland

854,208,437.14 751,703,424.68

3004900063




(incl. for tr

Israel

13,758,644.87 12,107,607.49

3004900063




(incl. for tr

Italy

357,254,912.31 314,384,322.83

3004900063




(incl. for tr

Japan

28,767,228.58 25,315,161.15

3004900063




(incl. for tr

Korea, Republic of

115,693.09 101,809.92

73

3004900063




(incl. for tr

Luxembourg

61,567.23 54,179.16

3004900063




(incl. for tr

Malaysia

918,056.22 807,889.47

3004900063




(incl. for tr

Malta

2,174,408.51 1,913,479.49

3004900063




(incl. for tr

Mexico

4,420,881.99 3,890,376.15

3004900063




(incl. for tr

Netherlands

136,642,273.63 120,245,200.79

3004900063




(incl. for tr

New Zealand

34,139,881.90 30,043,096.07

74

3004900063




(incl. for tr

Norway

278,960.90 245,485.59

3004900063




(incl. for tr

Pakistan

1,115.93 982.02

3004900063




(incl. for tr

Philippines

6,336,213.81 5,575,868.15

3004900063




(incl. for tr

Poland

6,613,351.48 5,819,749.30

3004900063




(incl. for tr

Portugal

487,391.86 428,904.84

3004900063




(incl. for tr

Puerto Rico

277,895,896.36 244,548,388.80

75

3004900063




(incl. for tr

Romania

140,064.93 123,257.14

3004900063




(incl. for tr

Samoa (American)

51,824.77 45,605.80

3004900063




(incl. for tr

Singapore

157,702,135.88 138,777,879.57

3004900063




(incl. for tr

Slovak Republic

662,359.41 582,876.28

3004900063




(incl. for tr

Slovenia

558,506.18 491,485.44

3004900063




(incl. for tr

South Africa

5,993,979.74 5,274,702.17

76

3004900063




(incl. for tr

Spain

522,308,059.03 459,631,091.95

3004900063




(incl. for tr

Sweden

308,484,406.05 271,466,277.32

3004900063




(incl. for tr

Switzerland

647,787,093.46 570,052,642.24

3004900063




(incl. for tr

Taiwan

257,130.66 226,274.98

3004900063




(incl. for tr

Tajikistan

2,032,463.90 1,788,568.23

3004900063




(incl. for tr

Thailand

1,191,012.57 1,048,091.06

77

3004900063




(incl. for tr

Tunisia

1,470.96 1,294.44

3004900063




(incl. for tr

Turkey

7,509,396.95 6,608,269.32

3004900063




(incl. for tr

United Arab Emirates

11,476.80 10,099.58

3004900063




(incl. for tr

United Kingdom

760,116,858.52 668,902,835.50

3004900063




(incl. for tr


574,392,260.50 505,465,189.24

3004900063




(incl. for tr

Viet Nam

3,736.96 3,288.52

78

3005100001

Adhesive dressings & other articles having an

adhesive layer, impregnated or coated

with pharmaceutical substances or put up in

forms or packings for retail sale for medical, surgical,

dental or veter


3,333.05 2,933.08

3005100001





dental or veter

Belgium

647,774.28 570,041.37

3005100001





dental or veter

Brazil

566,292.28 498,337.21

3005100001





dental or veter

Canada

19,076.95 16,787.72

3005100001





dental or veter

China

3,363,511.46 2,959,890.08

3005100001





dental or veter

Colombia

51,928.70 45,697.26

79

3005100001





dental or veter

Denmark

1,092,578.45 961,469.04

3005100001





dental or veter

Egypt

402,294.12 354,018.83

3005100001





dental or veter

Finland

5,587,422.05 4,916,931.40

3005100001





dental or veter

France

1,363,183.75 1,199,601.70

3005100001





dental or veter

Germany

2,996,486.10 2,636,907.77

3005100001





dental or veter


191,144.38 168,207.05

80

3005100001





dental or veter

Hungary

2,436,062.18 2,143,734.72

3005100001





dental or veter

India

980,515.80 862,853.90

3005100001





dental or veter

Indonesia

4,702.08 4,137.83

3005100001





dental or veter

Israel

12,576.06 11,066.93

3005100001





dental or veter

Italy

164,224.91 144,517.92

3005100001





dental or veter

Japan

2,907,811.11 2,558,873.78

81

3005100001





dental or veter

Korea, Republic of

383,604.56 337,572.01

3005100001





dental or veter

Macau (SAR of China)

1,876.56 1,651.37

3005100001





dental or veter

Malaysia

372,372.01 327,687.37

3005100001





dental or veter

Mexico

1,009,563.47 888,415.85

3005100001





dental or veter

Netherlands

2,864,896.11 2,521,108.58

3005100001





dental or veter

New Zealand

62,382.73 54,896.80

82

3005100001





dental or veter

Singapore

21,073.72 18,544.87

3005100001





dental or veter

Slovak Republic

1,651,675.20 1,453,474.18

3005100001





dental or veter

South Africa

1,597,563.40 1,405,855.79

3005100001





dental or veter

Spain

5,157,721.92 4,538,795.29

3005100001





dental or veter

Sweden

20,658.70 18,179.66

3005100001





dental or veter

Switzerland

90,739.18 79,850.48

83

3005100001





dental or veter

Taiwan

49,725.37 43,758.33

3005100001





dental or veter

Thailand

5,251,144.73 4,621,007.36

3005100001





dental or veter

Turkey

5,580.37 4,910.73

3005100001





dental or veter

United Kingdom

6,152,129.74 5,413,874.17

3005100001





dental or veter


13,149,804.16 11,571,827.66

3005100001





dental or veter

Viet Nam

6,772.08 5,959.43

84

3005901002

Wadding (incl. cotton wool and absorbent cotton) impregnated or coated

with pharmaceutical substances or for retail

sale for medical, surgical, dental or vet purposes (excl. adhesive & waste

products)

Belgium

9,782.26 8,608.39

3005901002




products)

Canada

1,382.06 1,216.21

3005901002




products)

China

695,318.66 611,880.42

3005901002




products)

Finland

274,941.51 241,948.53

3005901002




products)

France

17,035.58 14,991.31

3005901002




products)

Germany

165,220.03 145,393.63

85

3005901002




products)

Italy

11,204.16 9,859.66

3005901002




products)

Japan

10,631.53 9,355.75

3005901002




products)

Malaysia

131,917.50 116,087.40

3005901002




products)

Mexico

56,532.15 49,748.29

3005901002




products)

New Zealand

842,500.15 741,400.13

3005901002




products)

Switzerland

33,925.09 29,854.08

86

3005901002




products)

Taiwan

14,584.65 12,834.49

3005901002




products)

Turkey

131,796.04 115,980.52

3005901002




products)

United Kingdom

78,140.99 68,764.07

3005901002




products)


1,871,637.59 1,647,041.08

3005909003

Gauze, bandages & articles such as dressings

& poultices (excl. adhesive dressings,

wadding & waste products) impregnated or

coated with pharmaceutical

substances or for retail sale for medical, surgi


30,677.70 26,996.38

3005909003






Austria

11,168.62 9,828.39

87

3005909003






Belgium

1,751,332.21 1,541,172.34

3005909003






Bosnia and Herzegovina

85,425.23 75,174.20

3005909003






Canada

8,127,140.84 7,151,883.94

3005909003






China

18,978,044.76 16,700,679.39

3005909003






Czech Republic

12,413.43 10,923.82

88

3005909003






Denmark

790,772.16 695,879.50

3005909003






Dominican Republic

18,950.40 16,676.35

3005909003






Egypt

79,034.26 69,550.15

3005909003






Finland

24,277.38 21,364.09

3005909003






Former Yug Rep

Macedonia

24,886.88 21,900.45

89

3005909003






France

688,644.75 606,007.38

3005909003






Germany

4,126,932.04 3,631,700.20

3005909003







23,246.93 20,457.30

3005909003






Hungary

1,308.67 1,151.63

3005909003






India

1,678,445.71 1,477,032.22

90

3005909003






Indonesia

29,883.77 26,297.72

3005909003






Ireland

8,826.11 7,766.98

3005909003






Israel

38,695.99 34,052.47

3005909003






Italy

1,231,591.83 1,083,800.81

3005909003






Japan

601,413.99 529,244.31

91

3005909003






Korea, Dem People's Rep

1,855.00 1,632.40

3005909003






Korea, Republic of

129,581.23 114,031.48

3005909003






Malaysia

2,712,088.29 2,386,637.70

3005909003






Mexico

1,802,504.45 1,586,203.92

3005909003






Netherlands

8,214,154.45 7,228,455.92

92

3005909003






New Zealand

273,439.24 240,626.53

3005909003






Pakistan

11,050.81 9,724.71

3005909003






Philippines

2,929.22 2,577.71

3005909003






Poland

233,080.49 205,110.83

3005909003






Puerto Rico

30,047.32 26,441.64

93

3005909003






Russian Federation

1,898.27 1,670.48

3005909003






Singapore

28,161.85 24,782.43

3005909003






South Africa

85,492.08 75,233.03

3005909003






Sweden

167,016.74 146,974.73

3005909003






Switzerland

14,619.88 12,865.49

94

3005909003






Syria

4,601.78 4,049.57

3005909003






Taiwan

4,782,083.26 4,208,233.27

3005909003






Thailand

407,738.30 358,809.70

3005909003






United Kingdom

9,986,518.69 8,788,136.45

3005909003







8,403,400.79 7,394,992.70

3006101202

Sterile surgical & dental adhesion barriers, of

plates, sheets, film, foil & strip of polymers of

ethylene & styrene, PVC, polyvinyl butyral &

Malaysia

186,782.10 164,368.25

95

polyamides. For details, please see Tariff.

3006101303

Sterile surgical & dental adhesion barriers, of

plates, sheets, film, foil and strip of cellulose & deriv., amino-resins, phenolic resins, non-

cellular & not reinforced, lamin, supported or

combined w


53,866.30 47,402.34

3006101906

Sterile surgical or dental adhesion barriers,

whether or not absorbable, of plastics, nes. For details, please

see Tariff.

Canada

35,368.00 31,123.84

3006101906



see Tariff.

Italy

34,544.52 30,399.18

3006101906



see Tariff.

Switzerland

1,928.43 1,697.02

3006101906



see Tariff.


634,451.59 558,317.40

3006109010

Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for

surgical wound closure; sterile laminaria and

sterile laminaria tents; sterile absorbable surgical

or dental

Austria

716,152.59 630,214.28

3006109010




Belgium

7,458,663.58 6,563,623.95

96

or dental

3006109010




or dental

Brazil

10,584.96 9,314.76

3006109010




or dental

China

612,924.76 539,373.79

3006109010




or dental

Denmark

531,398.16 467,630.38

3006109010




or dental

Dominican Republic

474,748.36 417,778.56

3006109010




or dental

France

620,435.58 545,983.31

97

3006109010




or dental

Germany

1,158,345.36 1,019,343.92

3006109010




or dental

Hungary

2,743.18 2,414.00

3006109010




or dental

Iceland

1,352.92 1,190.57

3006109010




or dental

Ireland

5,328.27 4,688.88

3006109010




or dental

Israel

84,000.00 73,920.00

3006109010




or dental

Italy

94,471.91 83,135.28

98

3006109010




or dental

Japan

5,887.86 5,181.32

3006109010




or dental

Korea, Republic of

943,003.99 829,843.51

3006109010




or dental

Malaysia

831,713.29 731,907.70

3006109010




or dental

Mexico

190,998.75 168,078.90

3006109010




or dental

Netherlands

37,068.06 32,619.89

3006109010




or dental

New Zealand

22,709.92 19,984.73

99

3006109010




or dental

Norway

4,559.82 4,012.64

3006109010




or dental

Pakistan

2,514.22 2,212.51

3006109010




or dental

Portugal

2,467.83 2,171.69

3006109010




or dental

Singapore

12,501.21 11,001.06

3006109010




or dental

Spain

1,127,481.78 992,183.97

3006109010




or dental

Switzerland

747,925.26 658,174.23

100

3006109010




or dental

United Kingdom

1,875,285.03 1,650,250.83

3006109010




or dental


57,040,529.08 50,195,665.59 3006200007 Blood-grouping reagents Canada 1,016.77 894.76 3006200007 Blood-grouping reagents Germany 11,645.17 10,247.75 3006200007 Blood-grouping reagents Italy 13,906.66 12,237.86 3006200007 Blood-grouping reagents Switzerland 2,262,239.24 1,990,770.53

3006200007 Blood-grouping reagents United

Kingdom 207,617.84 182,703.70

3006200007 Blood-grouping reagents United States

of America 2,625,961.11 2,310,845.78

3006300009

Opacifying preparations for X-ray examinations;

diagnostic reagents designed to be

administered to the patient

Brazil

7,703.74 6,779.29

3006300009




Canada

4,064,121.05 3,576,426.52

3006300009




China

4,874,583.27 4,289,633.28

3006300009




Finland

108,802.24 95,745.97

3006300009




France

436,198.89 383,855.02

101

3006300009




Germany

8,014,489.96 7,052,751.16

3006300009





38,863.36 34,199.76

3006300009




India

1,934.29 1,702.18

3006300009




Ireland

1,424,386.32 1,253,459.96

3006300009




Italy

5,348,759.56 4,706,908.41

3006300009




Netherlands

222,158.79 195,499.74

3006300009




Norway

1,217,988.95 1,071,830.28

3006300009




Spain

1,197,329.91 1,053,650.32

3006300009




Sweden

1,441.64 1,268.64

3006300009




United Kingdom

361,905.46 318,476.80

3006300009





4,438,498.31 3,905,878.51

102

3006300009




Vanuatu

9,860.96 8,677.64

3006400010

Dental cements and other dental fillings; bone

reconstruction cements

Australia (Re-imports) 143,451.53 126,237.35

3006400010


reconstruction cements Austria

1,216.75 1,070.74

3006400010


reconstruction cements Belgium

238,936.06 210,263.73

3006400010


reconstruction cements Belize

1,795.83 1,580.33

3006400010


reconstruction cements Brazil

13,869.01 12,204.73

3006400010


reconstruction cements Canada

2,311.60 2,034.21

3006400010


reconstruction cements China

8,339.45 7,338.72

3006400010


reconstruction cements Denmark

18,515.80 16,293.90

3006400010


reconstruction cements France

99,182.15 87,280.29

3006400010


reconstruction cements Germany

7,598,384.98 6,686,578.78

3006400010


reconstruction cements Greece

8,441.72 7,428.71

3006400010


reconstruction cements Ireland

8,127,348.35 7,152,066.55

3006400010


reconstruction cements Italy

50,392.36 44,345.28

3006400010


reconstruction cements Japan

5,633,264.52 4,957,272.78

3006400010



Korea, Republic of 81,760.95 71,949.64

3006400010


reconstruction cements Mexico

41,598.19 36,606.41

3006400010 Dental cements and other

dental fillings; bone New Zealand 6,098.10 5,366.33

103


3006400010


reconstruction cements Singapore

5,735,522.09 5,047,259.44

3006400010


reconstruction cements Sweden

281,980.05 248,142.44

3006400010


reconstruction cements Switzerland

2,267,798.23 1,995,662.44

3006400010



United Kingdom 3,169,697.13 2,789,333.47

3006400010




4,757,099.00 4,186,247.12

3006400010


reconstruction cements Viet Nam

12,091.57 10,640.58

3006500025 First-aid boxes and kits Australia (Re-

imports) 44,108.66 38,815.62 3006500025 First-aid boxes and kits Belgium 5,983.28 5,265.29 3006500025 First-aid boxes and kits Canada 8,928.21 7,856.82 3006500025 First-aid boxes and kits China 2,408,294.52 2,119,299.18 3006500025 First-aid boxes and kits Egypt 36,146.40 31,808.83 3006500025 First-aid boxes and kits France 1,165.61 1,025.74 3006500025 First-aid boxes and kits Germany 2,987.22 2,628.75

3006500025 First-aid boxes and kits

Hong Kong (SAR of China) 50,444.34 44,391.02

3006500025 First-aid boxes and kits India 19,713.88 17,348.21 3006500025 First-aid boxes and kits Italy 41,584.55 36,594.40

3006500025 First-aid boxes and kits Korea,

Republic of 54,968.94 48,372.67

3006500025 First-aid boxes and kits New Zealand

44,165.39 38,865.54 3006500025 First-aid boxes and kits Philippines 22,187.71 19,525.18 3006500025 First-aid boxes and kits Singapore 10,089.31 8,878.59 3006500025 First-aid boxes and kits Sweden 1,226.90 1,079.67 3006500025 First-aid boxes and kits Switzerland 45,923.16 40,412.38 3006500025 First-aid boxes and kits Taiwan 6,175.45 5,434.40

3006500025 First-aid boxes and kits United

Kingdom 63,485.12 55,866.91

3006500025 First-aid boxes and kits United States

of America 140,185.14 123,362.92

3006600026

Chemical contraceptive preparations based on

hormones, on other products of 2937 or on

Belgium

104,069.84 91,581.46

104

spermicides

3006600026



spermicides

Fiji

159,877.52 140,692.22

3006600026



spermicides

Germany

39,861,632.54 35,078,236.64

3006600026



spermicides

Hungary

1,565,771.98 1,377,879.34

3006600026



spermicides

Ireland

3,430,476.35 3,018,819.19

3006600026



spermicides

Netherlands

11,148,015.84 9,810,253.94

3006600026



spermicides

New Zealand

15,252.57 13,422.26

3006600026



spermicides

United Kingdom

1,394,409.65 1,227,080.49

3006700040

Gel preparations designed to be used in human

medicine as a lubricant for parts of the body for

surgical operations or physical examinations or

as a coupling agent between the body and

medical instrum


3,150.00 2,772.00

3006700040





Canada

56,392.15 49,625.09

105

medical instrum

3006700040





medical instrum

China

9,116.85 8,022.83

3006700040





medical instrum

Costa Rica

2,455.00 2,160.40

3006700040





medical instrum

Germany

33,758.86 29,707.80

3006700040





medical instrum

Iran

2,455.00 2,160.40

3006700040





medical instrum

Israel

2,736.66 2,408.26

106

3006700040





medical instrum

Italy

112,286.17 98,811.83

3006700040





medical instrum

Japan

8,045.00 7,079.60

3006700040





medical instrum

Malaysia

2,640.00 2,323.20

3006700040





medical instrum

Netherlands

4,653.40 4,094.99

3006700040





medical instrum

New Zealand

39,584.62 34,834.47

3006700040





medical instrum

Switzerland

652,100.51 573,848.45

107

3006700040





medical instrum

Taiwan

29,093.35 25,602.15

3006700040





medical instrum

Thailand

575,419.97 506,369.57

3006700040





medical instrum

United Kingdom

213,307.38 187,710.49

3006700040





medical instrum


1,021,513.87 898,932.21

3006700042

Gel preparations designed to be used in veterinary




medical in

France

3,927.00 3,455.76

3006700042





medical in

Netherlands

1,723.86 1,517.00

108

3006700042





medical in

New Zealand

3,805.90 3,349.19

3006700042





medical in

United Kingdom

5,895.22 5,187.79

3006700042





medical in


32,902.76 28,954.43

3006910001 Appliances identifiable for

ostomy use Canada 1,147.37 1,009.69


ostomy use China 14,114.84 12,421.06


ostomy use Denmark 6,701,739.71 5,897,530.94


ostomy use Dominican Republic 1,729,285.34 1,521,771.10


ostomy use Germany 72,898.51 64,150.69


ostomy use Hungary 975,668.90 858,588.63


ostomy use Ireland 3,693,827.15 3,250,567.89


ostomy use Japan 2,715.07 2,389.26


ostomy use South Africa 1,101.25 969.10


ostomy use Spain 35,651.60 31,373.41


ostomy use Taiwan 217,052.44 191,006.15


ostomy use United

Kingdom 2,409,133.73 2,120,037.68

3006910001

Appliances identifiable for ostomy use


6,335,141.70 5,574,924.70

109

3006923007 Waste goods of Chapter

30, NSA Spain 76,764.04 67,552.36

3006923007 Waste goods of Chapter

30, NSA United

Kingdom 5,648.53 4,970.71

3006929005 Waste pharmaceuticals,

NSA China 2,787.82 2,453.28

3006929005 Waste pharmaceuticals,

NSA Germany 3,848.36 3,386.56

3006929005

Waste pharmaceuticals, NSA


2,503.88 2,203.41 Fuente ABS – Australian Bureau of Statistics

8 - Apéndice III – Evolución y Participación de Argentina – 2009

HTISC HTISC - Etiquetas Origen AUS$ U$S

3001200007


secretions Argentina

71,171.21 62,630.66

3004400059

Medicaments (excl. HS 3002, 3005 or 3006) mixed or unmixed, for therapeutic

or prophylactic use and contain alkaloids or derivs but not contain hormones

or products of 2937 or antibiotics, in measured

Argentina

977,582.97 860,273.01

3004900063


3006, with penicillin, antibiotics, hormones or

HS 2937, alkaloids or derivs & vitamins or HS 2936) in measured dose

(incl. for tr

Argentina

1,158,354.08 1,019,351.59 Fuente ABS – Australian Bureau of Statistics CONSULADO GENERAL DE ARGENTINA en Sydney Level 20, 44 Market St, Sydney NSW 2000 PO Box Q1613, QVB Post Office NSW 1230 Tel: +61 2 9262 2933 - Fax: +61 2 9262 3998 [email protected]

industria farmaceutica en australia

Documents